Directors & Officers
| Name | Title | Year Born |
|---|---|---|
| Dr. Paul F. Lizzul M.D. | Chief Medical Officer | 1975 |
| Mr. Ajim A. Tamboli C.F.A. | Chief Financial Officer | 1977 |
TRAX
First Tracks Biotherapeutics
Employees
104
Phone
858 362 6295
Fiscal year end
December
IPO
Apr 20, 2026
Address
10770 Wateridge Circle, San Diego, CA, United States, 92121
45.79
+0.57 (+1.25%)
USD · NASDAQ
52-week range
11.30
49.91
Trading at 89% of the 52-week range
Market Cap
1.90B
P/E Ratio
0.00
Forward P/E
0.00
Book Value
4.77
Div. Yield
N/A
% Institutions
88.96%
% Insiders
3.56%
1 Year
+256.9%3 Year
+256.9%10 Year
+256.9%Description
First Tracks Biotherapeutics, Inc. operates a clinical-stage biotechnology company focused on delivering immunology therapeutics for autoimmune and inflammatory diseases in United States. Its products includes ANB033, a novel anti-CD122 antagonist that targets the shared beta subunit of the IL-15 and IL-2 receptors; Rosnilimab, a antibody engineered to selectively deplete pathogenic T cells in both the periphery and inflamed tissues; and ANB101, a BDCA2-modulating antibody designed to specifically target plasmacytoid dendritic cells (pDCs). First Tracks Biotherapeutics, Inc. was formerly known as Biopharma Co., Inc. and changed its name to First Tracks Biotherapeutics, Inc. in February 2026. First Tracks Biotherapeutics, Inc. was founded in 2019 and is based in San Diego, California.
Actions
Add an action for TRAX.US, or sign in to see your action list.
People
Shareholders
Financial Highlights
Market Cap:
$1.90B
EBITDA:
$-169.08M
Book Value:
$4.77
Earnings/Share:
$-4.71
Profit Margin:
0.00%
Operating Margin:
0.00%
ROA (TTM):
-28.97%
ROE (TTM):
-48.92%
Revenue (TTM):
$0.00
Revenue/Share (TTM):
$0.00
Earnings Growth (YOY):
0.00%
Revenue Growth (YOY):
0.00%
Valuation Metrics
Enterprise Value:
$1.76B
Trailing P/E:
0.00
Forward P/E:
0.00
Shares Statistics
Shares Outstanding:
42.02M
Shares Float:
26.15M
% Insiders:
3.56%
% Institutions:
88.96%
Shares Short:
6.96M
Shares Short (Prior Month):
5.19M
Short Ratio:
6.01
Stock Price History
1 Year Price History
3 Years Price History
10 Years Price History
Max Price History
Financial Charts
Revenue, Net Income & Operating Cash Flow (Yearly)
Change % vs Prior Year
Revenue, Net Income & Operating Cash Flow (Quarterly)
Change % vs Prior Quarter
Operating Expenses (Yearly)
Operating Expenses (Quarterly)
Balance Sheet (Yearly)
Balance Sheet (Quarterly)
Assets Breakdown (Yearly)
Assets Breakdown (Quarterly)
Liabilities Breakdown (Yearly)
Liabilities Breakdown (Quarterly)
Income Statement Waterfall
No revenue data found for the selected year.
Earnings Per Share (EPS) History
Financial Ratios
📦 Raw API Data (JSON Explorer)
Comprehensive raw data returned from the EOD Fundamentals API. Expand sections below to drill down.